Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI3250 in Healthy Japanese Children
NCT02269475Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2014
- Primary completion
- Apr 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen in influenza, sponsored by AstraZeneca. Started Oct 2014; status: completed.
02
Drugs
Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02269475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02269475.